These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 8872062
1. Decrease in lipoprotein(a) after renal transplantation is related to the glucocorticoid dose. von Ahsen N, Helmhold M, Eisenhauer T, Armstrong VW, Oellerich M. Eur J Clin Invest; 1996 Aug; 26(8):668-75. PubMed ID: 8872062 [Abstract] [Full Text] [Related]
2. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation. Brown JH, Murphy BG, Douglas AF, Short CD, Bhatnagar D, Mackness MI, Hunt LP, Doherty CC, Durrington PN. Nephron; 1997 Aug; 75(3):277-82. PubMed ID: 9069448 [Abstract] [Full Text] [Related]
3. Cyclosporin A has divergent effects on plasma LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL-C and the elevation of Lp(a) concentrations in hemodialysis patients. Azrolan N, Brown CD, Thomas L, Hayek T, Zhao ZH, Roberts KG, Scheiner C, Friedman EA. Arterioscler Thromb; 1994 Sep; 14(9):1393-8. PubMed ID: 8068598 [Abstract] [Full Text] [Related]
4. Serum lipoprotein (a) levels in patients with chronic renal failure--evolution after renal transplantation and relationship with other parameters of lipoprotein metabolism: a prospective study. Segarra A, Chacón P, Martin M, Vilardell M, Vila J, Cotrina M, Fort J, Olmos A, Piera LL. Nephron; 1995 Sep; 69(1):9-13. PubMed ID: 7891807 [Abstract] [Full Text] [Related]
5. Early elevation of lipoprotein(a) levels in chronic renal insufficiency. De Lima JJ, Maranhão RC, Latrilha Mda C, Diament J, Romão JE, Krieger EM, Pileggi F. Ren Fail; 1997 Jan; 19(1):145-54. PubMed ID: 9044461 [Abstract] [Full Text] [Related]
6. The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients. Hilbrands LB, Demacker PN, Hoitsma AJ, Stalenhoef AF, Koene RA. J Am Soc Nephrol; 1995 Jun; 5(12):2073-81. PubMed ID: 7579056 [Abstract] [Full Text] [Related]
7. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients. Kimak E, Solski J. Ren Fail; 2002 Mar; 24(2):187-95. PubMed ID: 12071592 [Abstract] [Full Text] [Related]
8. Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up. Kerschdorfer L, König P, Neyer U, Bösmüller C, Lhotta K, Auinger M, Hohenegger M, Riegler P, Margreiter R, Utermann G, Dieplinger H, Kronenberg F. Atherosclerosis; 1999 Jun; 144(2):381-91. PubMed ID: 10407499 [Abstract] [Full Text] [Related]
9. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure. Sechi LA, Zingaro L, Catena C, Perin A, De Marchi S, Bartoli E. Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373 [Abstract] [Full Text] [Related]
10. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H. Ann Intern Med; 1993 Aug 15; 119(4):263-9. PubMed ID: 8328733 [Abstract] [Full Text] [Related]
11. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease. Querfeld U, Lang M, Friedrich JB, Kohl B, Fiehn W, Schärer K. Pediatr Res; 1993 Dec 15; 34(6):772-6. PubMed ID: 8108191 [Abstract] [Full Text] [Related]
12. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Hartgens F, Rietjens G, Keizer HA, Kuipers H, Wolffenbuttel BH. Br J Sports Med; 2004 Jun 15; 38(3):253-9. PubMed ID: 15155420 [Abstract] [Full Text] [Related]
13. Serum lipoprotein (a) levels in maintenance hemodialysis patients. Okura Y, Saku K, Hirata K, Zhang B, Liu R, Ogahara S, Naito S, Kajiyama G, Arakawa K. Nephron; 1993 Jun 15; 65(1):46-50. PubMed ID: 8413789 [Abstract] [Full Text] [Related]
14. Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation. Kronenberg F, König P, Lhotta K, Ofner D, Sandholzer C, Margreiter R, Dosch E, Utermann G, Dieplinger H. Arterioscler Thromb; 1994 Sep 15; 14(9):1399-404. PubMed ID: 8068599 [Abstract] [Full Text] [Related]
15. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure. Milionis HJ, Elisaf MS, Tselepis A, Bairaktari E, Karabina SA, Siamopoulos KC. Am J Kidney Dis; 1999 Jun 15; 33(6):1100-6. PubMed ID: 10352198 [Abstract] [Full Text] [Related]
16. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria. Wanner C, Bartens W, Nauck M, Zäuner I, Greiber S, Schollmeyer P. Miner Electrolyte Metab; 1996 Jun 15; 22(1-3):26-30. PubMed ID: 8676820 [Abstract] [Full Text] [Related]
17. Apo(a) phenotypes and lp(a) concentrations in renal transplant patients. Kandoussi AM, Hugue V, Cachera C, Hazzan M, Dracon M, Tacquet A, Noël C. Nephron; 1998 Oct 15; 80(2):183-7. PubMed ID: 9736817 [Abstract] [Full Text] [Related]
18. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration. Misra M, Webb AT, Reaveley DA, Doherty E, O'Donnell M, Seed M, Brown EA. Adv Perit Dial; 1997 Oct 15; 13():168-73. PubMed ID: 9360675 [Abstract] [Full Text] [Related]
19. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P. Kidney Int; 1999 Apr 15; 55(4):1536-42. PubMed ID: 10201020 [Abstract] [Full Text] [Related]
20. Lipoprotein(a) in renal disease. Kronenberg F, Utermann G, Dieplinger H. Am J Kidney Dis; 1996 Jan 15; 27(1):1-25. PubMed ID: 8546123 [Abstract] [Full Text] [Related] Page: [Next] [New Search]